首页> 美国卫生研究院文献>Bioscience Reports >Bioinformatics analysis of microRNAs related to blood stasis syndrome in diabetes mellitus patients
【2h】

Bioinformatics analysis of microRNAs related to blood stasis syndrome in diabetes mellitus patients

机译:糖尿病患者血瘀证相关微RNA的生物信息学分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In traditional Chinese medicine (TCM), blood stasis syndrome (BSS) is mainly manifested by the increase of blood viscosity, platelet adhesion rate and aggregation, and the change of microcirculation, resulting in vascular endothelial injury. It is an important factor in the development of diabetes mellitus (DM). The aim of the present study was to screen out the potential candidate microRNAs (miRNAs) in DM patients with BSS by high-throughput sequencing (HTS) and bioinformatics analysis. Human umbilical vein endothelial cells (HUVECs) were incubated with 10% human serum to establish models of DM with BSS, DM without BSS (NBS), and normal control (NC). Total RNA of each sample was extracted and sequenced by the Hiseq2000 platform. Differentially expressed miRNAs (DE-miRNAs) were screened between samples and compared with known changes in mRNA abundance. Target genes of miRNAs were predicted by softwares. Gene Ontology (GO) and pathway enrichment analysis of the target genes were conducted. According to the significantly enriched GO annotations and pathways (P-value ≤ 0.001), we selected the key miRNAs of DM with BSS. It showed that the number of DE-miRNAs in BSS was 32 compared with non-blood stasis syndrome (NBS) and NC. The potential candidate miRNAs were chosen from GO annotations in which target genes were significantly enriched (−log10 (P-value) > 5), which included miR-140-5p, miR-210, miR-362-5p, miR-590-3p, and miR-671-3p. The present study screened out the potential candidate miRNAs in DM patients with BSS by HTS and bioinformatics analysis. The miRNAs will be helpful to provide valuable suggestions on clinical studies of DM with BSS at the gene level.
机译:在中药(TCM)中,血瘀证(BSS)主要表现为血液粘度增加,血小板黏附率和聚集,微循环改变,导致血管内皮损伤。它是发展糖尿病(DM)的重要因素。本研究的目的是通过高通量测序(HTS)和生物信息学分析筛选出DM患者BSS中潜在的候选microRNA(miRNA)。将人脐静脉内皮细胞(HUVEC)与10%人血清温育,以建立具有BSS的DM,无BSS的DM(NBS)和正常对照(NC)的模型。通过Hiseq2000平台提取每个样品的总RNA并进行测序。在样品之间筛选差异表达的miRNA(DE-miRNA),并与mRNA丰度的已知变化进行比较。 miRNA的靶基因通过软件预测。进行了基因本体论(GO)和目标基因的途径富集分析。根据显着丰富的GO注释和途径(P值≤0.001),我们选择了具有BSS的DM的关键miRNA。结果表明,与非血瘀综合征(NBS)和NC相比,BSS中的DE-miRNA数量为32。从GO注释中选择了可能的候选miRNA,在这些注释中目标基因显着富集(-log10(P值)> 5),其中包括miR-140-5p,miR-210,miR-362-5p,miR-590- 3p和miR-671-3p。本研究通过HTS和生物信息学分析筛选出DM患者BSS中潜在的候选miRNA。 miRNA将有助于在基因水平上对BSS与DM的临床研究提供有价值的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号